Market Place
Sourcing Support
Novo Seeks Obesity Refresh with $550 M Replicate Deal
29 Aug 2025 //
FIERCE BIOTECH
Catalent`s Newly Acquired Novo Plant Under FDA Scrutiny
22 Aug 2025 //
FIERCE PHARMA
CDSCO issues Alert on Novo Drugs After Reported Theft
22 Aug 2025 //
ECONOMICTIMES
Natco Pharma Sues Novo Nordisk Over Generic Drug Push
21 Aug 2025 //
ECONOMICTIMES
Drugmaker Novo Nordisk Freezes Hiring for Non-Critical Jobs
21 Aug 2025 //
REUTERS
Novo to Showcase Wegovy & Ozempic Benefits at ESC Congress 2025
20 Aug 2025 //
GLOBENEWSWIRE
Canada Approves Ozempic to Cut Risk of Kidney Failure
20 Aug 2025 //
REUTERS
Wegovy`s Approval Highlights Viability of High-Dose Peptides
19 Aug 2025 //
BIOSPACE
Novo Nordisk A/S: Board Members and Executives Trade Shares
19 Aug 2025 //
GLOBENEWSWIRE
BioMed X, Novo Nordisk Launch Oral Peptide Delivery Project
19 Aug 2025 //
CONTRACTPHARMA
Novo Nordisk Unveils $499 Cash-Pay Ozempic Offering
19 Aug 2025 //
FIERCE PHARMA
Novo`s Wegovy Gets Accelerated Approval for Liver Disease MASH
18 Aug 2025 //
REUTERS
Obesity Drug Heavyweights` Battle
15 Aug 2025 //
FIERCE PHARMA
GLP-1s: The Cause of Novo Nordisk`s Swift Rise and Fall
13 Aug 2025 //
BIOSPACE
Novo Nordisk A/S: Board Members, Executives Trade Shares
12 Aug 2025 //
GLOBENEWSWIRE
Obesity Leaders Fortify Injectable GLP-1 Empires With Manufacture
12 Aug 2025 //
BIOSPACE
Novo Nordisk Discloses Board and Executive Share Trades
07 Aug 2025 //
GLOBENEWSWIRE
Novo Nordisk Drops 2 Obesity Drugs as Part of Major Clearout
07 Aug 2025 //
FIERCE BIOTECH
Novo`s new CEO Takes Over at Difficult Time for Drugmaker
07 Aug 2025 //
FIERCE PHARMA
Wegovy maker Novo Nordisk to Reduce Costs After $95 billion stock
06 Aug 2025 //
REUTERS
Maziar Mike Doustdar Named Novo Nordisk`s President and CEO
31 Jul 2025 //
INDPHARMAPOST
FDA Approves Alhemo for Hemophilia A/B Treatment in Children
31 Jul 2025 //
PR NEWSWIRE
Obesity Drug Trials Underway in Big and Small Pharma Labs
31 Jul 2025 //
ECONOMICTIMES
FuturHealth to Distribute Affordable FDA-Approved GLP-1s
30 Jul 2025 //
PR NEWSWIRE
Novo Nordisk Names New President & CEO
29 Jul 2025 //
CONTRACTPHARMA
Novo Nordisk Reduces 2025 Sales and Profit Forecast
29 Jul 2025 //
GLOBENEWSWIRE
Maziar Mike Doustdar Named Novo Nordisk`s President and CEO
29 Jul 2025 //
GLOBENEWSWIRE
EU Adopts Positive Opinion for Novo Nordisk’s Alhemo
25 Jul 2025 //
GLOBENEWSWIRE
Dr Reddy`s Plan to Launch Generic of Novo`s Weight-Loss Drug
24 Jul 2025 //
REUTERS
Fangzhou, Novo Nordisk Sign Memo for Health Management Ecosystem
20 Jul 2025 //
GLOBENEWSWIRE
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
Novo Nordisk’s Biologic Norditropin Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo’s Biologic Norditropin Flexpro Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo’s Biologics Norditropin Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo Nordisk`s Biologics Sogroya Receive Suppl Approval in US
09 Jul 2025 //
FDA
Novo Adds $112 M Quality Testing Lab to List of China Investments
09 Jul 2025 //
FIERCE PHARMA
Novo Nordisk seeks EMA Approval For higher Wegovy Dose in Obesity
09 Jul 2025 //
INDPHARMAPOST
Eli Lilly Launches Mounjaro KwikPen for Type 2 Diabetes in India
08 Jul 2025 //
ECONOMICTIMES
Mounjaro Hits Rs 50 Cr Milestone in India as Wegovy Enters Market
08 Jul 2025 //
ECONOMICTIMES
Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales
07 Jul 2025 //
BUSINESS STD
Novo`s Wegovy Retakes Top TV Spending Spot in June
07 Jul 2025 //
FIERCE PHARMA
Obesity Drugs Shoots up In India as Lilly, Novo for Market Share
07 Jul 2025 //
REUTERS
Delhi Hc Seeks Regulator`s Reply on Ozempic, Mounjaro Nod in Pil
03 Jul 2025 //
ECONOMICTIMES
Pros and Cons of Weight Loss Drugs
02 Jul 2025 //
EXPRESSPHARMA
Novo Misread the US Market for Its Weight Loss Sensation
02 Jul 2025 //
REUTERS
WeightWatchers, Novo Nordisk Expand Collaboration for Medication
01 Jul 2025 //
GLOBENEWSWIRE
India`s Biocon Drops Plan to Launch Weight-Loss Drugs in China
27 Jun 2025 //
REUTERS
Novo Nordisk Supports Patient Access to Wegovy and Safety
26 Jun 2025 //
PR NEWSWIRE
Novo Nordisk Launch $109M Protein Design Research Hub
25 Jun 2025 //
PR NEWSWIRE
Novo Nordisk Questioned Over Spanish Obesity Awareness Campaign
25 Jun 2025 //
FIERCE PHARMA
Weight-loss drug Wegovy starts at 17,345 in India
25 Jun 2025 //
ECONOMICTIMES
Novo Nordisk launches weight-loss drug Wegovy in India
25 Jun 2025 //
REUTERS
Novo Nordisk Aims for Heavy Sales in India with Wegovy
24 Jun 2025 //
#N/A
Novo Nordisk Ends Collaboration with Hims & Hers Health
24 Jun 2025 //
PR NEWSWIRE
EMA to Allow Novo to Include Heart Condition in Ozempic Label
24 Jun 2025 //
REUTERS
Novo Nordisk: Ozempic® recommended in EU for Peripheral Arterial
23 Jun 2025 //
GLOBENEWSWIRE
Novo Shares Fall as Obesity Pipeline Faces Investor Scrutiny
23 Jun 2025 //
REUTERS
Novo Nordisk: Mim8 Prophylaxis Well-Tolerated in Haemophilia A
22 Jun 2025 //
GLOBENEWSWIRE
Novo Nordisk`s experimental drug results in up to 24% weight loss
21 Jun 2025 //
PRESS RELEASE
Judge backs FDA`s Removal of Ozempic, Wegovy from Shortage list
18 Jun 2025 //
REUTERS
